• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, March 1, 2019


Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

An article from The American Journal of Managed Care®’s sister site The Center for Biosimilars® was highlighted by OBR Oncology’s daily newsfeed. The article, “Ahead of FDA Decision on its Pegfilgrastim Biosimilar, Sandoz Sues Amgen,” reported on Sandoz filing suit against Amgen, asking the United States District Court for the Northern District of California for a declaratory judgment of patent noninfringement and invalidity.

Related Videos
Virginia Kaklamani, MD | image credit: uthscsa.edu
Ruben A. Mesa, MD, president and executive director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Dr Guru Sonpavde
Video 2 - "Adverse Events & Existing Treatment Options for Dry Eye Disease"
Overview of Dry Eye Disease (DED) Causes and Treatments
Related Content
© 2023 MJH Life Sciences
All rights reserved.